Leflunomide and Movement - uncontrolled or slow - a phase IV clinical study of FDA data

Summary:

Movement - uncontrolled or slow is found among people who take Leflunomide, especially for people who are female, 30-39 old, have been taking the drug for 1 - 2 years.

The phase IV clinical study analyzes which people take Leflunomide and have Movement - uncontrolled or slow. It is created by eHealthMe based on reports of 67,544 people who have side effects when taking Leflunomide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 28, 2023

67,544 people reported to have side effects when taking Leflunomide.
Among them, 10 people (0.01%) have Movement - uncontrolled or slow.


What is Leflunomide?

Leflunomide has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 67,910 Leflunomide users for its effectiveness, alternative drugs and more.

What is Movement - uncontrolled or slow?

Movement - uncontrolled or slow is found to be associated with 2,068 drugs and 1,736 conditions by eHealthMe.

Number of Leflunomide and Movement - uncontrolled or slow reports submitted per year:

Could Leflunomide cause Movement - uncontrolled or slow?

Time on Leflunomide when people have Movement - uncontrolled or slow *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 100 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Movement - uncontrolled or slow when taking Leflunomide *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Movement - uncontrolled or slow when taking Leflunomide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 100 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Leflunomide *:

  1. Orencia: 9 people, 90.00%
  2. Imuran: 9 people, 90.00%
  3. Humira: 9 people, 90.00%
  4. Celebrex: 9 people, 90.00%
  5. Actemra: 9 people, 90.00%
  6. Ramipril: 8 people, 80.00%
  7. Prednisone: 8 people, 80.00%
  8. Methotrexate: 8 people, 80.00%
  9. Cyclosporine: 8 people, 80.00%
  10. Venlafaxine Hydrochloride: 2 people, 20.00%

Common side effects people have besides Movement - uncontrolled or slow *:

  1. High Blood Pressure: 9 people, 90.00%
  2. Drug Intolerance (drug sensitivity): 9 people, 90.00%
  3. Drug Ineffective: 9 people, 90.00%
  4. Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 10.00%
  5. Intervertebral Disc Protrusion (spinal disc protrusion): 1 person, 10.00%
  6. Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 1 person, 10.00%

Common conditions people have *:

  1. High Blood Pressure: 3 people, 30.00%
  2. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 10.00%
  3. Depression: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Leflunomide and have Movement - uncontrolled or slow?

Check whether Movement - uncontrolled or slow is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Movement - uncontrolled or slow and when was it recovered:

Expand to all the drugs that have ingredients of leflunomide:

Alternative drugs to, pros and cons of Leflunomide:

Common Leflunomide side effects:

Browse all side effects of Leflunomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Movement - uncontrolled or slow treatments and more:

COVID vaccines that are related to Movement - uncontrolled or slow:

Common drugs associated with Movement - uncontrolled or slow:

All the drugs that are associated with Movement - uncontrolled or slow:

Common conditions associated with Movement - uncontrolled or slow:

All the conditions that are associated with Movement - uncontrolled or slow:

How the study uses the data?

The study uses data from the FDA. It is based on leflunomide (the active ingredients of Leflunomide) and Leflunomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: